Cargando…

Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series

BACKGROUND: Oxymetazoline hydrochloride ophthalmic solution (0.1%) is a medication used to treat blepharoptosis. Patients who suffer from blepharoptosis have low-lying eyelids that can hinder their vision. Oxymetazoline hydrochloride ophthalmic solution (0.1%) is prescribed to patients to improve th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sung, Jonathan, Song, Alice, Song, Michael, Song, Julia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354271/ https://www.ncbi.nlm.nih.gov/pubmed/35927744 http://dx.doi.org/10.1186/s13256-022-03493-6

Ejemplares similares

Botulinum Toxin Therapy in Congenital Blepharospasm
por: Wabbels, Bettina
Publicado: (2014)

Injecting botulinum toxin into the treatment of blepharospasm
por: Popescu, Marius Nicolae, et al.
Publicado: (2018)

Association of Oxymetazoline Hydrochloride, 0.1%, Solution Administration With Visual Field in Acquired Ptosis: A Pooled Analysis of 2 Randomized Clinical Trials
por: Slonim, Charles B., et al.
Publicado: (2020)

Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
por: Hassell, Travis J.W., et al.
Publicado: (2020)

Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials
por: Wirta, David L, et al.
Publicado: (2021)

Botulinum toxin injections for blepharospasm prior to ocular surgeries
por: Okumus, Seydi, et al.
Publicado: (2012)

Botulinum a toxin treatment of hemifacial spasm and blepharospasm.
por: Park, Y. C., et al.
Publicado: (1993)

Blepharospasm Patients after Botulinum Toxin – Sleep Approach
por: Lestingi, Silvia, et al.
Publicado: (2023)

Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm
por: Wabbels, Bettina, et al.
Publicado: (2011)

THE EFFECT OF BOTULINUM TOXIN TYPE A IN PATIENTS WITH ESSENTIAL BLEPHAROSPASM
por: Gaćina, Klara, et al.
Publicado: (2022)

A Randomized Controlled Pilot Study: Combined 595‐nm Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride Topical Cream Superior to Oxymetazoline Hydrochloride Cream for Erythematotelangiectatic Rosacea
por: Sodha, Pooja, et al.
Publicado: (2021)

Efficacy of botulinum toxin in benign essential Blepharospasm: Desirable & undesirable effects
por: Anwar, M Shakaib, et al.
Publicado: (2013)

Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm
por: Dong, Hongjuan, et al.
Publicado: (2018)

Postural stability in blepharospasm: the effects of dual-tasking and botulinum toxin therapy
por: Balal, Mehmet, et al.
Publicado: (2023)

Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm – A Randomized Pilot Study
por: Silkiss, Rona Z., et al.
Publicado: (2023)

The Changes in Corneal Astigmatism after Botulinum Toxin-A Injection in Patients with Blepharospasm
por: Moon, Nam Ju, et al.
Publicado: (2006)

Treatment satisfaction with botulinum toxin: a comparison between blepharospasm and cervical dystonia
por: Leplow, Bernd, et al.
Publicado: (2017)

Oxymetazoline Hydrochloride Combined With Mometasone Nasal Spray for Persistent Nasal Congestion (Pilot Study)
por: Rael, Efren L, et al.
Publicado: (2011)

Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results
por: Bacharach, Jason, et al.
Publicado: (2021)

Comparable Botulinum Toxin Outcomes between Primary and Secondary Blepharospasm: A Retrospective Analysis
por: Martinez-Ramirez, Daniel, et al.
Publicado: (2014)

Oxymetazoline Hydrochloride Eye-Drops as Treatment for Myasthenia Gravis-Related Ptosis: A Description of Two Cases
por: Taha, Mohamed, et al.
Publicado: (2023)

Preseptal and Pretarsal Botulinum Toxin Injection in Hemifacial Spasm and Blepharospasm: A 10-Year Comparative Study
por: Teekaput, Chutithep, et al.
Publicado: (2023)

Effects of topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride on corneal sensitivity in rats
por: Lelescu, Cristina A., et al.
Publicado: (2020)

Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.2% ophthalmic solution evaluated by patient preference
por: McCabe, Craig F, et al.
Publicado: (2012)

Therapeutic Approach to Botulinum Injections for Hemifacial Spasm, Synkinesis and Blepharospasm
por: Yahalom, Gilad, et al.
Publicado: (2022)

Effects of the periocular botulinum toxin on the ocular surface and anterior chamber: a prospective study in patients with hemifacial spasm and blepharospasm
por: Romero-Caballero, María Dolores, et al.
Publicado: (2023)

Effects of brimonidine tartrate 0.1% ophthalmic solution on the pupil, refraction, and light reflex
por: Kato, C. O. Sayaka, et al.
Publicado: (2018)

Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm
por: Lee, Seunghyun, et al.
Publicado: (2018)

Outcomes of a regional variant of botulinum toxin type A in the treatment of essential blepharospasm and hemifacial spasms: A retrospective study
por: Maneksha, V, et al.
Publicado: (2021)

Comparative study of the ocular efficacy and safety of diclofenac sodium (0.1%) ophthalmic solution with that of ketorolac tromethamine (0.5%) ophthalmic solution in patients with acute seasonal allergic conjunctivitis
por: Dehar, Navdeep, et al.
Publicado: (2012)

Blink index as a response predictor of blepharospasm to botulinum neurotoxin‐A treatment
por: Jang, Jeongkyeong, et al.
Publicado: (2021)

Oxymetazoline Inhibits and Resolves Inflammatory Reactions in Human Neutrophils
por: Beck-Speier, Ingrid, et al.
Publicado: (2009)

Comparative analysis of the dispersion quality of oxymetazoline nasal sprays
por: Gobyzov, Oleg A., et al.
Publicado: (2022)

Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression
por: Yin, Bo, et al.
Publicado: (2021)

Subjective assessment of effectiveness, quality of life, and psychological status of patients receiving botulinum toxin therapy for hemifacial spasm, blepharospasm, or cervical dystonia
por: Kako, Tetsuharu, et al.
Publicado: (2021)

Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections
por: Miller, Darlene
Publicado: (2008)

To evaluate the efficacy and safety of olopatadine 0.1% ophthalmic solution and bepotastine 1.5% ophthalmic solution in patients with vernal keratoconjunctivitis in a tertiary care hospital
por: Sruthi, Vadlakonda, et al.
Publicado: (2020)

Blepharospasm
Publicado: (1892)

Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease
por: Burade, Vinod, et al.
Publicado: (2020)

Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy
por: Alexandru, Hanganu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ioo08cedeju4064v3459akdlns